TD Securities (USA)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$6K Buy
304
+2
+0.7% +$35 0.05% 157
2015
Q4
$6K Sell
302
-466
-61% -$8.35K 0.05% 157
2015
Q3
$13K Sell
768
-542,200
-100% -$9.27M 0.12% 182
2015
Q2
$9.61M Buy
542,968
+64,998
+14% +$1.16M 0.13% 184
2015
Q1
$8.48M Sell
477,970
-25,743
-5% -$407K 0.13% 191
2014
Q4
$6.67M Buy
503,713
+39,994
+9% +$511K 0.1% 257
2014
Q3
$5.48M Buy
463,719
+1,337
+0.3% +$16.8K 0.09% 266
2014
Q2
$5.91M Buy
462,382
+27,835
+6% +$362K 0.1% 249
2014
Q1
$5.88M Sell
434,547
-36,536
-8% -$480K 0.1% 232
2013
Q4
$5.66M Buy
471,083
+11,302
+2% +$134K 0.1% 257
2013
Q3
$5.4M Sell
459,781
-221
-0% -$2.39K 0.1% 236
2013
Q2
$4.26M Buy
+460,002
New +$3.9M 0.08% 289

Other funds holding BSX

TD Securities (USA)'s BSX Position: Q1 2016 in Review

TD Securities (USA) increased its Boston Scientific (BSX) stake by 0.66% in Q1 2016, buying an estimated $35 and bringing the position to 304 shares worth $6K. The position accounts for 0.05% of the portfolio, ranked #157.

TD Securities (USA) first reported a position in BSX in Q2 2013 and has held it in 12 quarters since. The position peaked at $9.61M in Q2 2015. 492 funds tracked by Wall St. Rank hold BSX as of Q1 2016.

  • TD Securities (USA) held 304 shares of Boston Scientific worth $6K as of Q1 2016.
  • TD Securities (USA) bought 2 Boston Scientific shares in Q1 2016, an estimated $35.
  • Boston Scientific made up 0.05% of TD Securities (USA)'s portfolio in Q1 2016, its #157 holding.
  • TD Securities (USA) first reported a position in Boston Scientific in Q2 2013 and has held it in 12 quarters since.
  • TD Securities (USA)'s Boston Scientific position peaked at $9.61M in Q2 2015.
  • 492 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.